Zinc binding compounds and their method of use
First Claim
Patent Images
1. A compound having the formula:
- wherein RX, RY, RX′ and
RY″
is hydrogen, C1-C6 alkyl or —
CH2CO2R, wherein R is H, a salt ion or CH2OC(O)CH3 with the proviso that at least one of RX, RY, RX′
or RY″
is hydrogen or said alkyl;
wherein R1, R2, R3, R4, R5, R6, R7 and R8 are independently selected from the group consisting of hydrogen, halogen, C1 to C6 alkyl (CH2), methoxy (—
OCH3), hydroxyl (—
OH), C2-C6 alkoxy (—
OCH2), alicyclic, heteroalicyclic, aryl, heteroaryl, amino (—
NR′
R″
), aldehyde, carboxyl, azido, nitro, nitroso, cyano, thioether, sulfinyl, reactive group, carrier molecule, solid support and reporter molecule;
or any two adjacent R1, R2, R3, R4, R5, R6, R7 and R8 substituents, form a fused reporter group;
wherein R′ and
R″
are independently selected from the group consisting of H, C1-C6 alkyl, substituted alkyl, C1-C6 carboxyalkyl (—
(CH)1-6COOR), an alpha-acyloxyalkyl, a biologically compatible salt, aryl, substituted aryl, aryl alkyl, substituted aryl alkyl, heteroaryl, and substituted heteroaryl;
wherein R9, R10, R11 and R12 are independently selected from the group consisting of hydrogen, lower alkyl, reactive group, carrier molecule, solid support and reactive molecule, or adjacent substituents R9 and R10 or R11 and R12 in combination constitute a 5-membered or 6-membered alicyclic or heterocyclic ring; and
, with the proviso that when said R3 or R6 is attached to a reporter molecule by a single covalent bond the reporter molecule is not 2,7-difluoro-3-hydroxyxanthen-6-one.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides a metal chelator and methods that facilitate binding, detecting, monitoring and quantitating of zinc ions in a sample. The metal chelating moiety of the zinc-binding compound is an analog of the well-known calcium chelator, BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N′N′-tetraacetic acid), wherein the chelating moiety has been modified from a tetraacetic acid moiety to a tri- di- or monoacetic moiety. This change in acetic acid groups on the metal chelating moiety results in the selective bindings of zinc ions in the presence of calcium ions, both of which are present in biological fluids and intracellular cytosolic fluid and organelles.
96 Citations
133 Claims
-
1. A compound having the formula:
-
wherein RX, RY, RX′ and
RY″
is hydrogen, C1-C6 alkyl or —
CH2CO2R, wherein R is H, a salt ion or CH2OC(O)CH3 with the proviso that at least one of RX, RY, RX′
or RY″
is hydrogen or said alkyl;
wherein R1, R2, R3, R4, R5, R6, R7 and R8 are independently selected from the group consisting of hydrogen, halogen, C1 to C6 alkyl (CH2), methoxy (—
OCH3), hydroxyl (—
OH), C2-C6 alkoxy (—
OCH2), alicyclic, heteroalicyclic, aryl, heteroaryl, amino (—
NR′
R″
), aldehyde, carboxyl, azido, nitro, nitroso, cyano, thioether, sulfinyl, reactive group, carrier molecule, solid support and reporter molecule;
or any two adjacent R1, R2, R3, R4, R5, R6, R7 and R8 substituents, form a fused reporter group;
wherein R′ and
R″
are independently selected from the group consisting of H, C1-C6 alkyl, substituted alkyl, C1-C6 carboxyalkyl (—
(CH)1-6COOR), an alpha-acyloxyalkyl, a biologically compatible salt, aryl, substituted aryl, aryl alkyl, substituted aryl alkyl, heteroaryl, and substituted heteroaryl;
wherein R9, R10, R11 and R12 are independently selected from the group consisting of hydrogen, lower alkyl, reactive group, carrier molecule, solid support and reactive molecule, or adjacent substituents R9 and R10 or R11 and R12 in combination constitute a 5-membered or 6-membered alicyclic or heterocyclic ring; and
,with the proviso that when said R3 or R6 is attached to a reporter molecule by a single covalent bond the reporter molecule is not 2,7-difluoro-3-hydroxyxanthen-6-one. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
and a biologically compatible anion.
-
-
25. A compound having the formula:
-
wherein RX, RY, RX′ and
RY″
is hydrogen, C1-C6 alkyl or —
CH2CO2R, wherein R is H, a salt ion or CH2OC(O)CH3 with the proviso that at least one of RX, RY, RX′
or RY″
is hydrogen or said alkyl;
wherein R1, R2, R3, R4, R5, R6, R7 and R8 are independently selected from the group consisting of hydrogen, halogen, C1 to C6 alkyl (CH2), methoxy (—
OCH3), hydroxyl (—
OH), C2-C6 alkoxy (—
OCH2), alicyclic, heteroalicyclic, aryl, heteroaryl, amino (—
NR′
R″
), aldehyde, carboxyl, azido, nitro, nitroso, cyano, thioether, sulfinyl, reactive group, carrier molecule, solid support and reporter molecule;
orany two adjacent R1, R2, R3, R4, R5, R6, R7 and R8 substituents, form a fused reporter group;
wherein R′ and
R″
are independently selected from the group consisting of H, C—
C6 alkyl, substituted alkyl, C1-C6 carboxyalkyl (—
(CH)1-6COOR), an alpha-acyloxyalkyl, a biologically compatible salt, aryl, substituted aryl, aryl alkyl, substituted aryl alkyl, heteroaryl, and substituted heteroaryl;
wherein R9, R10, R11 and R12 are independently selected from the group consisting of hydrogen, lower alkyl, reactive group, carrier molecule, solid support and reactive molecule, or adjacent substituents R9 and R10 or R11 and R12 in combination constitute a 5-membered or 6-membered alicyclic or heterocyclic ring; and
,with the proviso that at least one of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 is a reporter molecule or any two adjacent R1, R2, R3, R4, R5, R6, R7, and R8 substituents form a fused reporter molecule and with a further proviso that when said R3 or R6 is attached to a reporter molecule by a single covalent bond the reporter molecule is not 2,7-difluoro-3-hydroxyxanthen-6-one. - View Dependent Claims (26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)
with a biologically compatible anion, wherein R is CH2OC(O)CH3.
-
-
38. A composition comprising a metal ion selected from the group consisting of Zn2+, Fe3+, and Ca2+ and a compound according to the formula:
wherein RX, RY, RX′ and
RY″
is hydrogen, C1-C6 alkyl or —
CH2CO2R, wherein R is H, a salt ion or CH2OC(O)CH3 with the proviso that at least one of RX, RY, RX′
or RY″
is hydrogen or said alkyl;
wherein R1, R2, R3, R4, R5, R6, R7 and R8 are independently selected from the group consisting of hydrogen, halogen, C1 to C6 alkyl (CH2), methoxy (—
OCH3), hydroxyl (—
OH), C2-C6 alkoxy (—
OCH2), alicyclic, heteroalicyclic, aryl, heteroaryl, amino (—
NR′
R″
), aldehyde, carboxyl, azido, nitro, nitroso, cyano, thioether, sulfinyl, reactive group, carrier molecule, solid support and reporter molecule;
or any two adjacent R1, R2, R3, R4, R5, R6, R7 and R8 substituents, form a fused reporter group;
wherein R′ and
R″
are independently selected from the group consisting of H, C1-C6 alkyl, substituted alkyl, C1-C6 carboxyalkyl (—
(CH)1-6COOR), an alpha-acyloxyalkyl, a biologically compatible salt, aryl, substituted aryl, aryl alkyl, substituted aryl alkyl, heteroaryl, and substituted heteroaryl;
wherein R9, R10, R11 and R12 are independently selected from the group consisting of hydrogen, lower alkyl, reactive group, carrier molecule, solid support and reactive molecule, or adjacent substituents R9 and R10 or R11 and R12 in combination constitute a 5-membered or 6-membered alicyclic or heterocyclic ring; and
,with the proviso that when said R3 or R6 is attached to a reporter molecule by a single covalent bond the reporter molecule is not 2,7-difluoro-3-hydroxyxanthen-6-one. - View Dependent Claims (39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61)
-
62. A method for binding zinc ions in a sample wherein said method comprises combining compounds according to the formula:
wherein RX, RY, RX′ and
RY″
is hydrogen, C1-C6 alkyl or —
CH2CO2R, wherein R is H, a salt ion or CH2OC(O)CH3 with the proviso that at least one of RX, RY, RX′
or RY″
is hydrogen or said alkyl;
wherein RX, RY, RX′ and
RY″
is hydrogen, C1-C6 alkyl or —
CH2CO2R, wherein R is H, a salt ion or CH2OC(O)CH3 with the proviso that at least one of RX, RY, RX′
or RY″
is hydrogen or said alkyl;
wherein R1, R2, R3, R4, R5, R6, R7 and R8 are independently selected from the group consisting of hydrogen, halogen, C, to C6 alkyl (CH2), methoxy (—
OCH3), hydroxyl (—
OH), C2-C6 alkoxy (—
OCH2), alicyclic, heteroalicyclic, aryl, heteroaryl, amino (—
NR′
R″
), aldehyde, carboxyl, azido, nitro, nitroso, cyano, thioether, sulfinyl, reactive group, carrier molecule, solid support and reporter molecule;
orany two adjacent R1, R2, R3, R4, R5, R6, R7 and R8 substituents, form a fused reporter group;
wherein R′ and
R″
are independently selected from the group consisting of H, C1-C6 alkyl, substituted alkyl, C1-C6 carboxyalkyl (—
(CH)1-6COOR), an alpha-acyloxyalkyl, a biologically compatible salt, aryl, substituted aryl, aryl alkyl, substituted aryl alkyl, heteroaryl, and substituted heteroaryl;
wherein R9, R10, R11 and R12 are independently selected from the group consisting of hydrogen, lower alkyl, reactive group, carrier molecule, solid support and reactive molecule, or adjacent substituents R9 and R10 or R11 and R12 in combination constitute a 5-membered or 6-membered alicyclic or heterocyclic ring; and
,with the proviso that when said R3 or R6 is attached to a reporter molecule by a single covalent bond the reporter molecule is not 2,7-difluoro-3-hydroxyxanthen-6-one;
with a sample for a sufficient amount of time to allow said compound to bind zinc ions whereby zinc ions are bound. - View Dependent Claims (63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86)
-
87. A method for detecting zinc ions in a sample wherein said method comprises;
-
a) combining compounds according to the formula;
wherein RX, RY, RX′ and
RY″
is hydrogen, C1-C6 alkyl or —
CH2CO2R, wherein R is H, a salt ion or CH2OC(O)CH3 with the proviso that at least one of RX, RY, RX′
or RY″
is hydrogen or said alkyl;
wherein R1, R2, R3, R4, R5, R6, R7 and R8 are independently selected from the group consisting of hydrogen, halogen, C1 to C6 alkyl (CH2), methoxy (—
OCH3), hydroxyl (—
OH), C2-C6 alkoxy (—
OCH2), alicyclic, heteroalicyclic, aryl, heteroaryl, amino (—
NR′
R″
), aldehyde, carboxyl, azido, nitro, nitroso, cyano, thioether, sulfinyl, reactive group, carrier molecule, solid support and reporter molecule;
or any two adjacent R1, R2, R3, R4, R5, R6, R7 and R8 substituents, form a fused reporter group;
wherein R′ and
R″
are independently selected from the group consisting of H, C1-C6 alkyl, substituted alkyl, C1-C6 carboxyalkyl (—
(CH)1-6COOR), an alpha-acyloxyalkyl, a biologically compatible salt, aryl, substituted aryl, aryl alkyl, substituted aryl alkyl, heteroaryl, and substituted heteroaryl;
wherein R9, R10, R11 and R12 are independently selected from the group consisting of hydrogen, lower alkyl, reactive group, carrier molecule, solid support and reactive molecule, or adjacent substituents R9 and R10 or R11 and R12 in combination constitute a 5-membered or 6-membered alicyclic or heterocyclic ring; and
,with the proviso that at least one of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 is a reporter molecule or any two adjacent R1, R2, R3, R4, R5, R6, R7, and R8 substituents form a fused reporter molecule and with a further proviso that when said R3 or R6 is attached to a reporter molecule by a single covalent bond the reporter molecule is not 2,7-difluoro-3-hydroxyxanthen-6-one;
with a sample for a sufficient amount of time to allow said compound to bind zinc ions; and
,b) illuminating said sample with an appropriate wavelength whereby zinc ions are detected. - View Dependent Claims (88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108)
-
-
109. A kit comprising at least one compound according to the formula:
-
wherein RX, RY, RX and RX″
is hydrogen, C1-C6 alkyl or —
CH2CO2R, wherein R is H, a salt ion or CH2OC(O)CH3 with the proviso that at least one of RX, RY, RX′
or RY″
is hydrogen or said alkyl;
wherein R1, R2, R3, R4, R5, R6, R7 and R8 are independently selected from the group consisting of hydrogen, halogen, C1 to C6 alkyl (CH2), methoxy (—
OCH3), hydroxyl (—
OH), C2-C6 alkoxy (—
OCH2), alicyclic, heteroalicyclic, aryl, heteroaryl, amino (—
NR′
R″
), aldehyde, carboxyl, azido, nitro, nitroso, cyano, thioether, sulfinyl, reactive group, carrier molecule, solid support and reporter molecule;
or any two adjacent R1, R2, R3, R4, R5, R6, R7 and R8 substituents, form a fused reporter group;
wherein R′ and
R″
are independently selected from the group consisting of H, C1-C6 alkyl, substituted alkyl, C1-C6 carboxyalkyl (—
(CH)1-6COOR), an alpha-acyloxyalkyl, a biologically compatible salt, aryl, substituted aryl, aryl alkyl, substituted aryl alkyl, heteroaryl, and substituted heteroaryl;
wherein R9, R10, R11 and R12 are independently selected from the group consisting of hydrogen, lower alkyl, reactive group, carrier molecule, solid support and reactive molecule, or adjacent substituents R9 and R10 or R11 and R12 in combination constitute a 5-membered or 6-membered alicyclic or heterocyclic ring; and
,with the proviso that when said R3 or R6 is attached to a reporter molecule by a single covalent bond the reporter molecule is not 2,7-difluoro-3-hydroxyxanthen-6-one. - View Dependent Claims (110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133)
and a biologically compatible anion.
-
Specification